Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Human Growth Hormone Drugs Market Growth 2022-2028

  • LP 4922746
  • 93 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Human Growth Hormone Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Human Growth Hormone Drugs market size is USD million in 2022 from USD 237.7 million in 2021, with a change of % between 2021 and 2022. The global Human Growth Hormone Drugs market size will reach USD 319.5 million in 2028, growing at a CAGR of 4.3% over the analysis period.

The United States Human Growth Hormone Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Growth Hormone Drugs market, reaching US$ million by the year 2028. As for the Europe Human Growth Hormone Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Human Growth Hormone Drugs players cover Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech, Inc. (US), and GeneScience Pharmaceuticals Co., Ltd. (China), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Growth Hormone Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Norditropin

Genotropin

Humatrope

Saizen

Omnitrope - the Somatropin Biosimilar

Somatropin Biopartners

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Prader-Willi Syndrome

Turner Syndrome

Short Stature Homeobox Gene

Small for Gestational Age

Chronic Renal Insufficiency

Short Bowel Syndrome

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Eli Lilly and Company (US)

Ferring Holding SA (Switzerland)

Genentech, Inc. (US)

GeneScience Pharmaceuticals Co., Ltd. (China)

Merck KgaA (Germany)

Novo Nordisk A/S (Denmark)

Pfizer, Inc. (US)

Sandoz International GmbH (Germany)

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human Growth Hormone Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Human Growth Hormone Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Human Growth Hormone Drugs by Country/Region, 2017, 2022 & 2028

2.2 Human Growth Hormone Drugs Segment by Type

2.2.1 Norditropin

2.2.2 Genotropin

2.2.3 Humatrope

2.2.4 Saizen

2.2.5 Omnitrope - the Somatropin Biosimilar

2.2.6 Somatropin Biopartners

2.3 Human Growth Hormone Drugs Sales by Type

2.3.1 Global Human Growth Hormone Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Human Growth Hormone Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Human Growth Hormone Drugs Sale Price by Type (2017-2022)

2.4 Human Growth Hormone Drugs Segment by Application

2.4.1 Prader-Willi Syndrome

2.4.2 Turner Syndrome

2.4.3 Short Stature Homeobox Gene

2.4.4 Small for Gestational Age

2.4.5 Chronic Renal Insufficiency

2.4.6 Short Bowel Syndrome

2.5 Human Growth Hormone Drugs Sales by Application

2.5.1 Global Human Growth Hormone Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Human Growth Hormone Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Human Growth Hormone Drugs Sale Price by Application (2017-2022)

3 Global Human Growth Hormone Drugs by Company

3.1 Global Human Growth Hormone Drugs Breakdown Data by Company

3.1.1 Global Human Growth Hormone Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Human Growth Hormone Drugs Sales Market Share by Company (2020-2022)

3.2 Global Human Growth Hormone Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Human Growth Hormone Drugs Revenue by Company (2020-2022)

3.2.2 Global Human Growth Hormone Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Human Growth Hormone Drugs Sale Price by Company

3.4 Key Manufacturers Human Growth Hormone Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human Growth Hormone Drugs Product Location Distribution

3.4.2 Players Human Growth Hormone Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Growth Hormone Drugs by Geographic Region

4.1 World Historic Human Growth Hormone Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Human Growth Hormone Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Human Growth Hormone Drugs Annual Revenue by Geographic Region

4.2 World Historic Human Growth Hormone Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Human Growth Hormone Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Human Growth Hormone Drugs Annual Revenue by Country/Region

4.3 Americas Human Growth Hormone Drugs Sales Growth

4.4 APAC Human Growth Hormone Drugs Sales Growth

4.5 Europe Human Growth Hormone Drugs Sales Growth

4.6 Middle East & Africa Human Growth Hormone Drugs Sales Growth

5 Americas

5.1 Americas Human Growth Hormone Drugs Sales by Country

5.1.1 Americas Human Growth Hormone Drugs Sales by Country (2017-2022)

5.1.2 Americas Human Growth Hormone Drugs Revenue by Country (2017-2022)

5.2 Americas Human Growth Hormone Drugs Sales by Type

5.3 Americas Human Growth Hormone Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human Growth Hormone Drugs Sales by Region

6.1.1 APAC Human Growth Hormone Drugs Sales by Region (2017-2022)

6.1.2 APAC Human Growth Hormone Drugs Revenue by Region (2017-2022)

6.2 APAC Human Growth Hormone Drugs Sales by Type

6.3 APAC Human Growth Hormone Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Human Growth Hormone Drugs by Country

7.1.1 Europe Human Growth Hormone Drugs Sales by Country (2017-2022)

7.1.2 Europe Human Growth Hormone Drugs Revenue by Country (2017-2022)

7.2 Europe Human Growth Hormone Drugs Sales by Type

7.3 Europe Human Growth Hormone Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human Growth Hormone Drugs by Country

8.1.1 Middle East & Africa Human Growth Hormone Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Human Growth Hormone Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Human Growth Hormone Drugs Sales by Type

8.3 Middle East & Africa Human Growth Hormone Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Human Growth Hormone Drugs

10.3 Manufacturing Process Analysis of Human Growth Hormone Drugs

10.4 Industry Chain Structure of Human Growth Hormone Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Human Growth Hormone Drugs Distributors

11.3 Human Growth Hormone Drugs Customer

12 World Forecast Review for Human Growth Hormone Drugs by Geographic Region

12.1 Global Human Growth Hormone Drugs Market Size Forecast by Region

12.1.1 Global Human Growth Hormone Drugs Forecast by Region (2023-2028)

12.1.2 Global Human Growth Hormone Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Human Growth Hormone Drugs Forecast by Type

12.7 Global Human Growth Hormone Drugs Forecast by Application

13 Key Players Analysis

13.1 Eli Lilly and Company (US)

13.1.1 Eli Lilly and Company (US) Company Information

13.1.2 Eli Lilly and Company (US) Human Growth Hormone Drugs Product Offered

13.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Eli Lilly and Company (US) Main Business Overview

13.1.5 Eli Lilly and Company (US) Latest Developments

13.2 Ferring Holding SA (Switzerland)

13.2.1 Ferring Holding SA (Switzerland) Company Information

13.2.2 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Offered

13.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Ferring Holding SA (Switzerland) Main Business Overview

13.2.5 Ferring Holding SA (Switzerland) Latest Developments

13.3 Genentech, Inc. (US)

13.3.1 Genentech, Inc. (US) Company Information

13.3.2 Genentech, Inc. (US) Human Growth Hormone Drugs Product Offered

13.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Genentech, Inc. (US) Main Business Overview

13.3.5 Genentech, Inc. (US) Latest Developments

13.4 GeneScience Pharmaceuticals Co., Ltd. (China)

13.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Company Information

13.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Offered

13.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Main Business Overview

13.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) Latest Developments

13.5 Merck KgaA (Germany)

13.5.1 Merck KgaA (Germany) Company Information

13.5.2 Merck KgaA (Germany) Human Growth Hormone Drugs Product Offered

13.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Merck KgaA (Germany) Main Business Overview

13.5.5 Merck KgaA (Germany) Latest Developments

13.6 Novo Nordisk A/S (Denmark)

13.6.1 Novo Nordisk A/S (Denmark) Company Information

13.6.2 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Offered

13.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Novo Nordisk A/S (Denmark) Main Business Overview

13.6.5 Novo Nordisk A/S (Denmark) Latest Developments

13.7 Pfizer, Inc. (US)

13.7.1 Pfizer, Inc. (US) Company Information

13.7.2 Pfizer, Inc. (US) Human Growth Hormone Drugs Product Offered

13.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Pfizer, Inc. (US) Main Business Overview

13.7.5 Pfizer, Inc. (US) Latest Developments

13.8 Sandoz International GmbH (Germany)

13.8.1 Sandoz International GmbH (Germany) Company Information

13.8.2 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Offered

13.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sandoz International GmbH (Germany) Main Business Overview

13.8.5 Sandoz International GmbH (Germany) Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Human Growth Hormone Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Human Growth Hormone Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Norditropin

Table 4. Major Players of Genotropin

Table 5. Major Players of Humatrope

Table 6. Major Players of Saizen

Table 7. Major Players of Omnitrope - the Somatropin Biosimilar

Table 8. Major Players of Somatropin Biopartners

Table 9. Global Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Human Growth Hormone Drugs Sales Market Share by Type (2017-2022)

Table 11. Global Human Growth Hormone Drugs Revenue by Type (2017-2022) & ($ million)

Table 12. Global Human Growth Hormone Drugs Revenue Market Share by Type (2017-2022)

Table 13. Global Human Growth Hormone Drugs Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Human Growth Hormone Drugs Sales Market Share by Application (2017-2022)

Table 16. Global Human Growth Hormone Drugs Revenue by Application (2017-2022)

Table 17. Global Human Growth Hormone Drugs Revenue Market Share by Application (2017-2022)

Table 18. Global Human Growth Hormone Drugs Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Human Growth Hormone Drugs Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Human Growth Hormone Drugs Sales Market Share by Company (2020-2022)

Table 21. Global Human Growth Hormone Drugs Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Human Growth Hormone Drugs Revenue Market Share by Company (2020-2022)

Table 23. Global Human Growth Hormone Drugs Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Human Growth Hormone Drugs Producing Area Distribution and Sales Area

Table 25. Players Human Growth Hormone Drugs Products Offered

Table 26. Human Growth Hormone Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Human Growth Hormone Drugs Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Human Growth Hormone Drugs Sales Market Share Geographic Region (2017-2022)

Table 31. Global Human Growth Hormone Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Human Growth Hormone Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Human Growth Hormone Drugs Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Human Growth Hormone Drugs Sales Market Share by Country/Region (2017-2022)

Table 35. Global Human Growth Hormone Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Human Growth Hormone Drugs Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Human Growth Hormone Drugs Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Human Growth Hormone Drugs Sales Market Share by Country (2017-2022)

Table 39. Americas Human Growth Hormone Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Human Growth Hormone Drugs Revenue Market Share by Country (2017-2022)

Table 41. Americas Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Human Growth Hormone Drugs Sales Market Share by Type (2017-2022)

Table 43. Americas Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Human Growth Hormone Drugs Sales Market Share by Application (2017-2022)

Table 45. APAC Human Growth Hormone Drugs Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Human Growth Hormone Drugs Sales Market Share by Region (2017-2022)

Table 47. APAC Human Growth Hormone Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Human Growth Hormone Drugs Revenue Market Share by Region (2017-2022)

Table 49. APAC Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Human Growth Hormone Drugs Sales Market Share by Type (2017-2022)

Table 51. APAC Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Human Growth Hormone Drugs Sales Market Share by Application (2017-2022)

Table 53. Europe Human Growth Hormone Drugs Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Human Growth Hormone Drugs Sales Market Share by Country (2017-2022)

Table 55. Europe Human Growth Hormone Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Human Growth Hormone Drugs Revenue Market Share by Country (2017-2022)

Table 57. Europe Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Human Growth Hormone Drugs Sales Market Share by Type (2017-2022)

Table 59. Europe Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Human Growth Hormone Drugs Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Human Growth Hormone Drugs Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Human Growth Hormone Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Human Growth Hormone Drugs Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Human Growth Hormone Drugs Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Human Growth Hormone Drugs Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Human Growth Hormone Drugs

Table 70. Key Market Challenges & Risks of Human Growth Hormone Drugs

Table 71. Key Industry Trends of Human Growth Hormone Drugs

Table 72. Human Growth Hormone Drugs Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Human Growth Hormone Drugs Distributors List

Table 75. Human Growth Hormone Drugs Customer List

Table 76. Global Human Growth Hormone Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Human Growth Hormone Drugs Sales Market Forecast by Region

Table 78. Global Human Growth Hormone Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Human Growth Hormone Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Human Growth Hormone Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Human Growth Hormone Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Human Growth Hormone Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Human Growth Hormone Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Human Growth Hormone Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Human Growth Hormone Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Human Growth Hormone Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Human Growth Hormone Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Human Growth Hormone Drugs Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Human Growth Hormone Drugs Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Human Growth Hormone Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Human Growth Hormone Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Human Growth Hormone Drugs Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Human Growth Hormone Drugs Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Human Growth Hormone Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Human Growth Hormone Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 96. Eli Lilly and Company (US) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors

Table 97. Eli Lilly and Company (US) Human Growth Hormone Drugs Product Offered

Table 98. Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. Eli Lilly and Company (US) Main Business

Table 100. Eli Lilly and Company (US) Latest Developments

Table 101. Ferring Holding SA (Switzerland) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors

Table 102. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Offered

Table 103. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. Ferring Holding SA (Switzerland) Main Business

Table 105. Ferring Holding SA (Switzerland) Latest Developments

Table 106. Genentech, Inc. (US) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors

Table 107. Genentech, Inc. (US) Human Growth Hormone Drugs Product Offered

Table 108. Genentech, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. Genentech, Inc. (US) Main Business

Table 110. Genentech, Inc. (US) Latest Developments

Table 111. GeneScience Pharmaceuticals Co., Ltd. (China) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors

Table 112. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Offered

Table 113. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. GeneScience Pharmaceuticals Co., Ltd. (China) Main Business

Table 115. GeneScience Pharmaceuticals Co., Ltd. (China) Latest Developments

Table 116. Merck KgaA (Germany) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors

Table 117. Merck KgaA (Germany) Human Growth Hormone Drugs Product Offered

Table 118. Merck KgaA (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. Merck KgaA (Germany) Main Business

Table 120. Merck KgaA (Germany) Latest Developments

Table 121. Novo Nordisk A/S (Denmark) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors

Table 122. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Offered

Table 123. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 124. Novo Nordisk A/S (Denmark) Main Business

Table 125. Novo Nordisk A/S (Denmark) Latest Developments

Table 126. Pfizer, Inc. (US) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors

Table 127. Pfizer, Inc. (US) Human Growth Hormone Drugs Product Offered

Table 128. Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 129. Pfizer, Inc. (US) Main Business

Table 130. Pfizer, Inc. (US) Latest Developments

Table 131. Sandoz International GmbH (Germany) Basic Information, Human Growth Hormone Drugs Manufacturing Base, Sales Area and Its Competitors

Table 132. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Offered

Table 133. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 134. Sandoz International GmbH (Germany) Main Business

Table 135. Sandoz International GmbH (Germany) Latest Developments

List of Figures

Figure 1. Picture of Human Growth Hormone Drugs

Figure 2. Human Growth Hormone Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human Growth Hormone Drugs Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Human Growth Hormone Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Human Growth Hormone Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Norditropin

Figure 10. Product Picture of Genotropin

Figure 11. Product Picture of Humatrope

Figure 12. Product Picture of Saizen

Figure 13. Product Picture of Omnitrope - the Somatropin Biosimilar

Figure 14. Product Picture of Somatropin Biopartners

Figure 15. Global Human Growth Hormone Drugs Sales Market Share by Type in 2021

Figure 16. Global Human Growth Hormone Drugs Revenue Market Share by Type (2017-2022)

Figure 17. Human Growth Hormone Drugs Consumed in Prader-Willi Syndrome

Figure 18. Global Human Growth Hormone Drugs Market: Prader-Willi Syndrome (2017-2022) & (K Pcs)

Figure 19. Human Growth Hormone Drugs Consumed in Turner Syndrome

Figure 20. Global Human Growth Hormone Drugs Market: Turner Syndrome (2017-2022) & (K Pcs)

Figure 21. Human Growth Hormone Drugs Consumed in Short Stature Homeobox Gene

Figure 22. Global Human Growth Hormone Drugs Market: Short Stature Homeobox Gene (2017-2022) & (K Pcs)

Figure 23. Human Growth Hormone Drugs Consumed in Small for Gestational Age

Figure 24. Global Human Growth Hormone Drugs Market: Small for Gestational Age (2017-2022) & (K Pcs)

Figure 25. Human Growth Hormone Drugs Consumed in Chronic Renal Insufficiency

Figure 26. Global Human Growth Hormone Drugs Market: Chronic Renal Insufficiency (2017-2022) & (K Pcs)

Figure 27. Human Growth Hormone Drugs Consumed in Short Bowel Syndrome

Figure 28. Global Human Growth Hormone Drugs Market: Short Bowel Syndrome (2017-2022) & (K Pcs)

Figure 29. Global Human Growth Hormone Drugs Sales Market Share by Application (2017-2022)

Figure 30. Global Human Growth Hormone Drugs Revenue Market Share by Application in 2021

Figure 31. Human Growth Hormone Drugs Revenue Market by Company in 2021 ($ Million)

Figure 32. Global Human Growth Hormone Drugs Revenue Market Share by Company in 2021

Figure 33. Global Human Growth Hormone Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 34. Global Human Growth Hormone Drugs Revenue Market Share by Geographic Region in 2021

Figure 35. Global Human Growth Hormone Drugs Sales Market Share by Region (2017-2022)

Figure 36. Global Human Growth Hormone Drugs Revenue Market Share by Country/Region in 2021

Figure 37. Americas Human Growth Hormone Drugs Sales 2017-2022 (K Pcs)

Figure 38. Americas Human Growth Hormone Drugs Revenue 2017-2022 ($ Millions)

Figure 39. APAC Human Growth Hormone Drugs Sales 2017-2022 (K Pcs)

Figure 40. APAC Human Growth Hormone Drugs Revenue 2017-2022 ($ Millions)

Figure 41. Europe Human Growth Hormone Drugs Sales 2017-2022 (K Pcs)

Figure 42. Europe Human Growth Hormone Drugs Revenue 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Human Growth Hormone Drugs Sales 2017-2022 (K Pcs)

Figure 44. Middle East & Africa Human Growth Hormone Drugs Revenue 2017-2022 ($ Millions)

Figure 45. Americas Human Growth Hormone Drugs Sales Market Share by Country in 2021

Figure 46. Americas Human Growth Hormone Drugs Revenue Market Share by Country in 2021

Figure 47. United States Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Canada Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Mexico Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Brazil Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. APAC Human Growth Hormone Drugs Sales Market Share by Region in 2021

Figure 52. APAC Human Growth Hormone Drugs Revenue Market Share by Regions in 2021

Figure 53. China Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Japan Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. South Korea Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Southeast Asia Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. India Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Australia Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Europe Human Growth Hormone Drugs Sales Market Share by Country in 2021

Figure 60. Europe Human Growth Hormone Drugs Revenue Market Share by Country in 2021

Figure 61. Germany Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. France Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. UK Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Italy Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Russia Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Country in 2021

Figure 67. Middle East & Africa Human Growth Hormone Drugs Revenue Market Share by Country in 2021

Figure 68. Egypt Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 69. South Africa Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 70. Israel Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 71. Turkey Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 72. GCC Country Human Growth Hormone Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 73. Manufacturing Cost Structure Analysis of Human Growth Hormone Drugs in 2021

Figure 74. Manufacturing Process Analysis of Human Growth Hormone Drugs

Figure 75. Industry Chain Structure of Human Growth Hormone Drugs

Figure 76. Channels of Distribution

Figure 77. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390